Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia

被引:100
作者
Meyer Sauteur, Patrick M. [1 ]
Theiler, Martin [2 ,3 ]
Buettcher, Michael [4 ]
Seiler, Michelle [5 ]
Weibel, Lisa [2 ,3 ]
Berger, Christoph [1 ]
机构
[1] Univ Childrens Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[2] Univ Childrens Hosp Zurich, Div Pediat Dermatol, Zurich, Switzerland
[3] Univ Hosp Zurich, Dermatol Dept, Zurich, Switzerland
[4] Childrens Hosp Lucerne, Div Infect Dis, Luzern, Switzerland
[5] Univ Childrens Hosp Zurich, Emergency Dept, Zurich, Switzerland
关键词
STEVENS-JOHNSON-SYNDROME; INDUCED RASH; MUCOSITIS;
D O I
10.1001/jamadermatol.2019.3602
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Importance The diagnosis of Mycoplasma pneumoniae infection as the cause of mucocutaneous disease is challenging because current diagnostic tests are not able to differentiate M pneumoniae infection from carriage. Objective To examine the frequency and clinical presentation of M pneumoniae-induced mucocutaneous disease in children with community-acquired pneumonia (CAP) using improved diagnostics. Design, Setting, and Participants This prospective, longitudinal cohort study included 152 children aged 3 to 18 years with CAP enrolled in a CAP study from May 1, 2016, to April 30, 2017, at the University Children's Hospital Zurich. Children were inpatients or outpatients with clinically defined CAP according to the British Thoracic Society guidelines. Data analysis was performed from July 10, 2017, to June 29, 2018. Main Outcomes and Measures Frequency and clinical presentation of M pneumoniae-induced mucocutaneous disease in childhood CAP. Mycoplasma pneumoniae infection was diagnosed by polymerase chain reaction (PCR) of oropharyngeal samples and confirmed with the measurement of specific peripheral blood IgM antibody-secreting cells by enzyme-linked immunospot assay to differentiate M pneumoniae-infected patients from carriers with CAP caused by other pathogens. Mucocutaneous disease was defined as any eruptive lesion that involved skin and/or mucous membranes occurring during the CAP episode. Results Among 152 enrolled children with CAP (median [interquartile range] age, 5.7 [4.3-8.9] years; 84 [55.3%] male), 44 (28.9%) tested positive for M pneumoniae by PCR; of these, 10 children (22.7%) developed mucocutaneous lesions. All 10 patients with mucocutaneous eruptions tested positive for specific IgM antibody-secreting cells. Skin manifestations were found in 3 cases (2.8%) of M pneumoniae PCR-negative CAP (P < .001). The spectrum of M pneumoniae-induced mucocutaneous disease included M pneumoniae-induced rash and mucositis (3 cases [6.8%]), urticaria (2 cases [4.5%]), and maculopapular skin eruptions (5 cases [11.4%]). Two patients had ocular involvement as the sole mucosal manifestation (bilateral anterior uveitis and nonpurulent conjunctivitis). Patients with M pneumoniae-induced mucocutaneous disease had longer duration of prodromal fever (median [interquartile range], 10.5 [8.3-11.8] vs 7.0 [5.5-9.5] days; P = .02) and higher C-reactive protein levels (median [interquartile range], 31 [22-59] vs 16 [7-23] mg/L; P = .04) than patients with CAP due to M pneumoniae without mucocutaneous manifestations. They were also more likely to require oxygen (5 [50%] vs 1 [5%]; P = .007), to require hospitalization (7 [70%] vs 4 [19%]; P = .01), and to develop long-term sequelae (3 [30%] vs 0; P = .03). Conclusions and Relevance Mucocutaneous disease occurred significantly more frequently in children with CAP due to M pneumoniae than in children with CAP of other origins. Mycoplasma pneumoniae-induced mucocutaneous disease was associated with increased systemic inflammation, morbidity, and a higher risk of long-term sequelae. Question What are the frequency and clinical characteristics of Mycoplasma pneumoniae-induced mucocutaneous disease in children with community-acquired pneumonia (CAP)? Findings In this cohort study of 152 children with CAP, mucocutaneous eruptions developed in 10 of 44 patients (22.7%) with CAP due to M pneumoniae and 3 of 108 patients (2.8%) with CAP of other causes, a significant difference. Among patients with M pneumoniae infection, mucocutaneous disease was significantly associated with longer duration of fever, higher C-reactive protein level, and greater likelihood of hospitalization, oxygen use, and sequelae. Meaning The findings suggest that mucocutaneous disease is a frequent manifestation of M pneumoniae infection in children and is associated with increased systemic inflammation, morbidity, and a higher risk of long-term sequelae.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 15 条
[1]   Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causes [J].
Amode, Reyhan ;
Ingen-Housz-Oro, Saskia ;
Ortonne, Nicolas ;
Bounfour, Touda ;
Pereyre, Sabine ;
Schlemmer, Frederic ;
Bequignon, Emilie ;
Royer, Gerard ;
Wolkenstein, Pierre ;
Chosidow, Olivier .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) :110-117
[2]   Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review [J].
Canavan, Theresa N. ;
Mathes, Erin F. ;
Frieden, Ilona ;
Shinkai, Kanade .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (02) :239-U265
[3]   Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children [J].
Gardiner, Samantha J. ;
Gavranich, John B. ;
Chang, Anne B. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01)
[4]   Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR [J].
Hardegger, D ;
Nadal, D ;
Bossart, W ;
Altwegg, M ;
Dutly, F .
JOURNAL OF MICROBIOLOGICAL METHODS, 2000, 41 (01) :45-51
[5]   British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 [J].
Harris, Michael ;
Clark, Julia ;
Coote, Nicky ;
Fletcher, Penny ;
Harnden, Anthony ;
McKean, Michael ;
Thomson, Anne .
THORAX, 2011, 66 :II1-II23
[6]   Community-Acquired Pneumonia Requiring Hospitalization among US Children [J].
Jain, Seema ;
Williams, Derek J. ;
Arnold, Sandra R. ;
Ampofo, Krow ;
Bramley, Anna M. ;
Reed, Carrie ;
Stockmann, Chris ;
Anderson, Evan J. ;
Grijalva, Carlos G. ;
Self, Wesley H. ;
Zhu, Yuwei ;
Patel, Anami ;
Hymas, Weston ;
Chappell, James D. ;
Kaufman, Robert A. ;
Kan, J. Herman ;
Dansie, David ;
Lenny, Noel ;
Hillyard, David R. ;
Haynes, Lia M. ;
Levine, Min ;
Lindstrom, Stephen ;
Winchell, Jonas M. ;
Katz, Jacqueline M. ;
Erdman, Dean ;
Schneider, Eileen ;
Hicks, Lauri A. ;
Wunderink, Richard G. ;
Edwards, Kathryn M. ;
Pavia, Andrew T. ;
McCullers, Jonathan A. ;
Finelli, Lyn .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :835-845
[7]   Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae-Induced Rash and Mucositis Concept [J].
Mayor-Ibarguren, Ander ;
Feito-Rodriguez, Marta ;
Gonzalez-Ramos, Jessica ;
del Rosal-Rabes, Teresa ;
Javier Gonzalez-Sainz, Francisco ;
Sanchez-Orta, Alba ;
de Lucas-Laguna, Raul .
PEDIATRIC DERMATOLOGY, 2017, 34 (04) :465-472
[8]   Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome [J].
Olson, Daniel ;
Watkins, Louise K. Francois ;
Demirjian, Alicia ;
Lin, Xia ;
Robinson, Christine C. ;
Pretty, Kristin ;
Benitez, Alvaro J. ;
Winchell, Jonas M. ;
Diaz, Maureen H. ;
Miller, Lisa A. ;
Foo, Teresa A. ;
Mason, Melanie D. ;
Lauper, Ursula L. ;
Kupfer, Oren ;
Kennedy, Jeffrey ;
Glode, Mary P. ;
Kutty, Preeta K. ;
Dominguez, Samuel R. .
PEDIATRICS, 2015, 136 (02) :E386-E394
[9]  
Pediatric Dermatology Research Alliance (PeDRA), RED SEV CUT REACT CH
[10]   Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells [J].
Sauteur, Patrick M. Meyer ;
Seiler, Michelle ;
Truck, Johannes ;
Unger, Wendy W. J. ;
Paioni, Paolo ;
Relly, Christa ;
Staubli, Georg ;
Haas, Thorsten ;
Gysin, Claudine ;
Bachmann, Lucas M. ;
van Rossum, Annemarie M. C. ;
Berger, Christoph .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (08) :1066-1069